Zobrazeno 1 - 10
of 482
pro vyhledávání: '"Nancy M. Albert"'
Autor:
W. Frank Peacock, Abhay Dhand, Nancy M. Albert, Zainab Shahid, Alfred Luk, Kathleen Vollman, Reagan B. Schoppelrey, Cynthia Cadwell, Sanjeet Dadwal, Alpesh N. Amin, Francesca J. Torriani
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 6, Pp 1001-1006 (2024)
The current standard of stethoscope hygiene doesn’t eliminate the transmission of harmful pathogens, including multi-drug resistant organisms (MDROs). In the era of the increasing prevalence of MDRO infections, the use of new systems providing touc
Externí odkaz:
https://doaj.org/article/3b45e008630a4d74a127e5a60063fea6
Autor:
Suzanne Oskouie, MD, Ambarish Pandey, MD, MSCS, Andrew J. Sauer, MD, Stephen J. Greene, MD, Wilfried Mullens, MD, PhD, Muhammad Shahzeb Khan, MD, MSc, Kieran L. Quinn, MD, PhD, Jennifer E. Ho, MD, Nancy M. Albert, PhD, Harriette GC. Van Spall, MD, MPH
Publikováno v:
JACC: Advances, Vol 3, Iss 9, Pp 101131- (2024)
Heart failure (HF) is a leading cause of hospitalization in older adults. Patients are at high risk of readmission and death following hospitalization for HF. There is no standard approach of health care delivery during the hospital-to-home transitio
Externí odkaz:
https://doaj.org/article/76cf31bffd3d4d7f8467f0476677e04d
Autor:
Qinglan Ding, Erica S. Spatz, James F. Bena, Shannon L. Morrison, Michelle Levay, Haiqun Lin, Margaret Grey, Nancy E. Edwards, Diana Isaacs, Lucianne West, Pamela Combs, Nancy M. Albert
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 17 (2023)
Background It is unknown if initiation of a sodium‐glucose cotransporter‐2 inhibitor (SGLT‐2i) is associated with changes in patient‐reported health status outside of clinical trials. Methods and Results Using a prospective observational stud
Externí odkaz:
https://doaj.org/article/45c06a17ffbc447ba6d0be556d6f2147
Autor:
Josephine Harrington, Jie‐Lena Sun, Gregg C. Fonarow, Stephen B. Heitner, Punag H. Divanji, Gary Binder, Larry A. Allen, Brooke Alhanti, Clyde W. Yancy, Nancy M. Albert, Adam D. DeVore, G. Michael Felker, Stephen J. Greene
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 10 (2023)
Background Many patients with heart failure (HF) have severely reduced ejection fraction but do not meet threshold for consideration of advanced therapies (ie, stage D HF). The clinical profile and health care costs associated with these patients in
Externí odkaz:
https://doaj.org/article/1562516935a04e21a697a6a639dfaab1
Autor:
Adam D. DeVore, Claude Larry Hill, Laine E. Thomas, Nancy M. Albert, Javed Butler, J. Herbert Patterson, Adrian F. Hernandez, Fredonia B. Williams, Xian Shen, John A. Spertus, Gregg C. Fonarow
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 178-185 (2022)
Abstract Aims We aimed to develop a risk prediction tool that incorporated both clinical events and worsening health status for patients with heart failure (HF) with reduced ejection fraction (HFrEF). Identifying patients with HFrEF at increased risk
Externí odkaz:
https://doaj.org/article/01086c1b2af64c2caf40b7cb0ad58f19
Autor:
Merrill Thomas, Yevgeniy Khariton, Gregg C. Fonarow, Suzanne V. Arnold, Larry Hill, Michael E. Nassif, Paul S. Chan, Javed Butler, Laine Thomas, Adam D. DeVore, Adrian F. Hernandez, Nancy M. Albert, J. Herbert Patterson, Fredonia B. Williams, John A. Spertus
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2670-2678 (2021)
Abstract Aims Improving the health status (symptoms, function, and quality of life) of patients with heart failure with reduced ejection fraction (HFrEF) is a primary treatment goal. Angiotensin receptor neprilysin inhibitors (ARNI) improve short‐t
Externí odkaz:
https://doaj.org/article/aebdf592abe7418b8de3475a42c74e82
Autor:
Brittany Chapman, Anne S. Hellkamp, Laine E. Thomas, Nancy M. Albert, Javed Butler, J. Herbert Patterson, Adrian F. Hernandez, Fredonia B. Williams, Xian Shen, John A. Spertus, Gregg C. Fonarow, Adam D. DeVore
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background There are limited data on the use of angiotensin receptor neprilysin inhibitors (ARNIs) in minority populations with heart failure (HF) with reduced ejection fraction. We used data from the CHAMP‐HF (Change the Management of Patients Wit
Externí odkaz:
https://doaj.org/article/3cb9b1f5e4c6464fa83aedf2ffba96d0
Autor:
Yevgeniy Khariton, Gregg C. Fonarow, Ann Hellkamp, Laine Thomas, Michael E. Nassif, Javed Butler, Carol I. Duffy, Nancy M. Albert, John A. Spertus
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 710-713 (2021)
Abstract Aims The aim of our study was to investigate heterogeneity of health status treatment response of sacubitril/valsartan in patients with heart failure with reduced ejection fraction (HFrEF). Methods and results We leveraged data from CHAMP‐
Externí odkaz:
https://doaj.org/article/3feff0a78e874ecc8375f7440dc0cb3e
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 9 (2019)
Background Outcomes data among patients with heart failure (HF) with reduced ejection fraction treated with sacubitril/valsartan (SAC/VAL) are largely limited to clinical trial results. We compared hospitalization and healthcare costs among real‐wo
Externí odkaz:
https://doaj.org/article/d6bf6943c66e442a8e4df6006ad9d1b9
Autor:
Adam D. DeVore, Xiaojuan Mi, Laine Thomas, Puza P. Sharma, Nancy M. Albert, Javed Butler, Adrian F. Hernandez, J. Herbert Patterson, John A. Spertus, Fredonia B. Williams, Carol I. Duffy, Kevin McCague, Gregg C. Fonarow
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 12 (2018)
Background The US Food and Drug Administration approved sacubitril/valsartan for patients with chronic heart failure (HF) with reduced ejection fraction in 2015 on the basis of the results of the PARADIGM‐HF (Prospective Comparison of ARNI [Angiote
Externí odkaz:
https://doaj.org/article/1ae5053f8c89415cacbe7298ff71a0e6